Moreover, the rapid oxidation of succinate by SDH may be inhibited by the administration of DMM on reperfusion, leading to a reduction in mitochondrial ROS production and the occurrence of MiETosis which may be a novel strategy for treatment of ischemic stroke. The gene discussed is SDHB; the disease is ischemic stroke.